SLP logo

Simulations Plus (SLP)

Profile

Full Name

Simulations Plus, Inc.

Ticker Symbol

SLP

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

June 18, 1997

Indexes

Not included

Website

http://www.simulations-plus.com

Employees

243

Key Details

Price

$23.46

Market Cap

$471.37M(Small cap)

Last Dividend

$0.06

TTM Dividend Yield

0.51%

Annual Revenue

$70.01M(+17.52% YoY)

Annual EPS

$0.49(0.00% YoY)

PE Ratio

58.65

Next earnings date

Apr 3, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.46
SLP price is $23.46

Price All-time High

$89.52
SLP price is currently -73.79% below its historical high of $89.52

Price Today Change

-4.01%
SLP price is down -4.01% today

Price YTD Change

-16.84%
SLP price is down -16.84% since January 1st

Price 1-year Change

-43.88%
SLP price is down -43.88% year-on-year

Price 3-year Change

-54.68%
SLP price is down -54.68% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$471.37M
SLP market capitalization is $471.37 million

Market Cap 3-year Change

-54.88%
SLP market capitalization is down -54.88% over the past 3 years

Market Cap All-time High

$1.79B
SLP market capitalization is currently -73.63% below its historical high of $1.79 billion

Market Cap Sector Rank

68.5%
SLP market capitalization is higher than 68.5% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.54%
SLP shares outstanding is up +0.54% year-on-year

Shares Outstanding 3-Year Change

-0.44%
SLP shares outstanding is down -0.44% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.01
SLP beta is 1.01

200-day SMA

$33.28
SLP price is currently -29.51% below its 200-day simple moving average

50-day SMA

$30.31
SLP price is currently -22.60% below its 50-day simple moving average

RSI

36.30
SLP 14-day relative strength index is 36.30

Volume

0.99
SLP 30-day relative volume is 0.99

ATR

$1.28
SLP average true range is $1.28

10-day Historical Volatility

38.62%
SLP 10-day historical volatility is 38.62%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.06
SLP last dividend was $0.06 per share, with an ex-dividend date of July 29, 2024

Next Dividend

-
SLP next dividend has not yet been announced

Dividend per share

Dividend Per Share

$0.24
SLP annual dividend per share is $0.24

Dividend per share Sector Rank

9.3%
SLP annual dividend per share is higher than 9.3% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
SLP {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

0%
SLP {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Dividend Yield

1.02%
SLP annual dividend yield is 1.02%

Dividend yield Sector Rank

30.59%
SLP annual dividend yield is higher than 30.59% of companies in Healthcare sector

Other

Payout Ratio

48.18%
SLP annual payout ratio is 48.18%

Dividends Paid

$4.80M
SLP annual dividends paid is $4.80 million

Free Cash Flow

$9.02M
SLP annual free cash flow is $9.02 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$70.01M
SLP annual revenue is $70.01 million

Revenue Analysts Estimate

$90.40M
SLP annual revenue is currently -22.55% lower than the consensus analysts' forecast

Revenue 1-year Change

+17.52%
SLP annual revenue is up +17.52% year-on-year

Revenue Sector Rank

53.45%
SLP annual revenue is higher than 53.45% of companies in Healthcare sector

EPS

EPS

$0.49
SLP annual earnings per share is $0.49

EPS Analysts Estimate

$1.09
SLP annual earnings per share is currently -54.87% lower than the consensus analysts' forecast

EPS 1-year Change

0%
SLP {parameterFullLabel} has remained unchanged year-on-year

EPS Sector Rank

86.62%
SLP annual earnings per share is higher than 86.62% of companies in Healthcare sector

Profit

Gross Profit

$43.15M
SLP annual gross profit is $43.15 million

Gross Margin

61.63%
SLP annual gross profit margin is 61.63%

Operating Profit

$6.13M
SLP annual operating income is $6.13 million

Operating Margin

8.76%
SLP annual operating profit margin is 8.76%

Net Income

$9.95M
SLP annual net profit is $9.95 million

Net Margin

14.22%
SLP annual net profit margin is 14.22%

Expenses

Total Expenses

$63.88M
SLP annual total expenses is $63.88 million

Operating Expenses

$37.02M
SLP annual total operating expenses is $37.02 million

Cost Of Goods Sold

$26.86M
SLP annual cost of goods sold is $26.86 million

Selling, General & Administrative Expenses

$31.27M
SLP annual SGA is $31.27 million

Depreciation And Amortization

$5.67M
SLP annual depreciation & amortization is $5.67 million

Interest Expense

-
SLP annual interest expense value is unknown

Income Tax

$2.46M
SLP annual income tax is $2.46 million

EBIT & EBITDA

EBIT

$6.13M
SLP annual earnings before interest & taxes is $6.13 million

EBITDA

$6.13M
SLP annual EBITDA is $6.13 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$196.64M
SLP annual total assets is $196.64 million

Non Current Assets

$157.30M
SLP annual long term assets is $157.30 million

Current Assets

$39.34M
SLP annual total current assets is $39.34 million

Cash And Cash Equivalents

$10.31M
SLP annual cash & cash equivalents is $10.31 million

Accounts Receivable

$9.14M
SLP annual accounts receivable is $9.14 million

Inventory

-
SLP annual inventory value is unknown

Liabilities

Total Liabilities

$14.21M
SLP annual total liabilities is $14.21 million

Long Term Liabilities

$2.14M
SLP annual total long term liabilities is $2.14 million

Current Liabilities

$12.07M
SLP annual total current liabilities is $12.07 million

Accounts Payable

$602.00K
SLP annual accounts payable is $602.00 thousand

Debt

Total Debt

$1.01M
SLP annual total debt is $1.01 million

Total Debt 1-year Change

-15.96%
SLP annual total debt is down -15.96% year-on-year

Long Term Debt

$531.00K
SLP annual long term debt is $531.00 thousand

Short Term Debt

$475.00K
SLP annual short term debt is $475.00 thousand

Equity & Capital

Shareholders Equity

$182.43M
SLP annual stockholders equity is $182.43 million

Book Value

$182.43M
SLP annual book value is $182.43 million

Retained Earnings

$30.35M
SLP annual retained earnings is $30.35 million

Working Capital

$27.27M
SLP annual working capital is $27.27 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$13.32M
SLP annual cash flow from operations is $13.32 million

Cash From Operations 1-year Change

-39.06%
SLP annual cash flow from operations is down -39.06% year-on-year

Cash From Investing

-$53.97M
SLP annual cash flow from investing activities is -$53.97 million

Cash From Investing 1-year Change

-832.65%
SLP annual cash flow from investing activities is down -832.65% year-on-year

Cash From Financing

-$6.57M
SLP annual cash flow from financing activities is -$6.57 million

Cash From Financing 1-year Change

+71.78%
SLP annual cash flow from financing activities is up +71.78% year-on-year

CAPEX

CAPEX

$4.30M
SLP annual capital expenditures is $4.30 million

CAPEX 1-year Change

+0.66%
SLP annual capital expenditures is up +0.66% year-on-year

Free Cash Flow

Free Cash Flow

$9.02M
SLP annual free cash flow is $9.02 million

Free Cash Flow 1-year Change

-48.71%
SLP annual free cash flow is down -48.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

61.63%
SLP annual gross profit margin is 61.63%

Operating Margin

8.76%
SLP annual operating profit margin is 8.76%

Net Margin

14.22%
SLP annual net profit margin is 14.22%

ROA & ROE

ROA

5.20%
SLP annual return on assets is 5.20%

ROE

5.65%
SLP annual return on equity is 5.65%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

58.65
SLP price to earnings ratio is 58.65

PE Ratio Sector Rank

83.01%
SLP price to earnings ratio is higher than 83.01% of companies in Healthcare sector

PB Ratio

PB Ratio

2.55
SLP price to book ratio is 2.55

PB Ratio Sector Rank

68.88%
SLP price to book ratio is higher than 68.88% of companies in Healthcare sector

PS Ratio

PS Ratio

6.33
SLP price to sales ratio is 6.33

PS Ratio Sector Rank

71.45%
SLP price to sales ratio is higher than 71.45% of companies in Healthcare sector

Enterprise value

Enterprise Value

$466.50M
SLP enterprise value is $466.50 million

Enterprise Value Sector Rank

68.73%
SLP enterprise value is higher than 68.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

38.44
SLP EV/EBITDA is 38.44

EV/EBITDA Sector Rank

95.64%
SLP EV/EBITDA is higher than 95.64% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

3.26
SLP annual current ratio is 3.26

Quick Ratio

-
SLP annual quick ratio value is unknown

Leverage

Debt To Equity

0.00
SLP annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
SLP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
SLP piotroski f-score is 5

Altman Z-Score

20.75
SLP altman z-score is 20.75

Analyst ratings

Recent major analysts updates

Jan 24, 25 Keybanc
Overweight
Jan 8, 25 Keybanc
Overweight
Nov 15, 24 Stephens & Co.
Overweight
Nov 6, 24 William Blair
Outperform
Oct 24, 24 William Blair
Outperform
Oct 24, 24 BTIG
Buy
Sep 12, 24 William Blair
Outperform
Jul 29, 24 Keybanc
Overweight
Jul 16, 24 JMP Securities
Market Perform
Jul 3, 24 Craig-Hallum
Buy

Institutional Ownership

Similar stocks

MDRX logo
Veradigm (MDRX)
MGTX logo
MeiraGTx Holdings (MGTX)
SVA logo
Sinovac Biotech (SVA)
ARVN logo
Arvinas (ARVN)
Beta Bionics (BBNX)
CTKB logo
Cytek Biosciences (CTKB)
SAGE logo
Sage Therapeutics (SAGE)
URGN logo
UroGen Pharma (URGN)
TALK logo
Talkspace (TALK)
  • What is the ticker symbol for Simulations Plus?
  • Does Simulations Plus pay dividends?
  • What sector is Simulations Plus in?
  • What industry is Simulations Plus in?
  • What country is Simulations Plus based in?
  • When did Simulations Plus go public?
  • Is Simulations Plus in the S&P 500?
  • Is Simulations Plus in the NASDAQ 100?
  • Is Simulations Plus in the Dow Jones?
  • When was Simulations Plus's last earnings report?
  • When does Simulations Plus report earnings?
  • Should I buy Simulations Plus stock now?

What is the ticker symbol for Simulations Plus?

The ticker symbol for Simulations Plus is NASDAQ:SLP

Does Simulations Plus pay dividends?

Yes, Simulations Plus pays dividends. The last payment was $0.06, with an ex-dividend date on July 29, 2024

What sector is Simulations Plus in?

Simulations Plus is in the Healthcare sector

What industry is Simulations Plus in?

Simulations Plus is in the Health Information Services industry

What country is Simulations Plus based in?

Simulations Plus is headquartered in United States

When did Simulations Plus go public?

Simulations Plus's initial public offering (IPO) was on June 18, 1997

Is Simulations Plus in the S&P 500?

No, Simulations Plus is not included in the S&P 500 index

Is Simulations Plus in the NASDAQ 100?

No, Simulations Plus is not included in the NASDAQ 100 index

Is Simulations Plus in the Dow Jones?

No, Simulations Plus is not included in the Dow Jones index

When was Simulations Plus's last earnings report?

Simulations Plus's most recent earnings report was on Jan 7, 2025

When does Simulations Plus report earnings?

The next expected earnings date for Simulations Plus is Apr 3, 2025

Should I buy Simulations Plus stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page